These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32634388)

  • 21. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
    Zhang J; Gui YH; Yang Y
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
    Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
    PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease.
    Chang LS; Chen KD; Huang YH; Kuo HC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease.
    Saito K; Nakaoka H; Takasaki I; Hirono K; Yamamoto S; Kinoshita K; Miyao N; Ibuki K; Ozawa S; Watanabe K; Bowles NE; Ichida F
    Pediatr Res; 2016 Sep; 80(3):425-32. PubMed ID: 27089500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of miRNA-122 in Kawasaki disease.
    Lv HF; Sun XQ; Zhou HX; Qin Z; Shi YY; Wang Q; Li F
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11222-11226. PubMed ID: 33215440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease.
    Jia HL; Liu CW; Zhang L; Xu WJ; Gao XJ; Bai J; Xu YF; Xu MG; Zhang G
    Sci Rep; 2017 Mar; 7():44706. PubMed ID: 28317854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease.
    Ko TM; Kuo HC; Chang JS; Chen SP; Liu YM; Chen HW; Tsai FJ; Lee YC; Chen CH; Wu JY; Chen YT
    Circ Res; 2015 Feb; 116(5):876-83. PubMed ID: 25605650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Ferritin as a Diagnostic Biomarker for Kawasaki Disease.
    Kim SH; Song ES; Yoon S; Eom GH; Kang G; Cho YK
    Ann Lab Med; 2021 May; 41(3):318-322. PubMed ID: 33303717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study.
    Lin J; Zhao H; Jiao F; Ma L; Wang W; Ma L
    J Trop Pediatr; 2020 Apr; 66(2):171-177. PubMed ID: 31302704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
    Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
    Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating adipokines are associated with Kawasaki disease.
    Zhang XY; Yang TT; Hu XF; Wen Y; Fang F; Lu HL
    Pediatr Rheumatol Online J; 2018 May; 16(1):33. PubMed ID: 29739418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
    Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
    Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial glycocalyx components as a predictive marker of coronary artery lesions in Kawasaki disease.
    Ohnishi Y; Yasudo H; Suzuki Y; Furuta T; Matsuguma C; Azuma Y; Miyake A; Okada S; Ichihara K; Ohga S; Hasegawa S
    Int J Cardiol; 2019 Oct; 292():236-240. PubMed ID: 31200965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in and significance of platelet function and parameters in Kawasaki disease.
    Zheng X; Wu W; Zhang Y; Wu G
    Sci Rep; 2019 Nov; 9(1):17641. PubMed ID: 31776411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
    Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease.
    Yun KW; Lee JY; Yun SW; Lim IS; Choi ES
    Pediatr Cardiol; 2014 Jun; 35(5):745-52. PubMed ID: 24259014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.
    Chang LS; Lo MH; Li SC; Yang MY; Hsieh KS; Kuo HC
    Oncotarget; 2017 Jan; 8(2):2044-2052. PubMed ID: 27893416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease.
    Li SC; Huang LH; Chien KJ; Pan CY; Lin PH; Lin Y; Weng KP; Tsai KW
    Mol Genet Genomic Med; 2019 Dec; 7(12):e990. PubMed ID: 31605468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.